Pay in 4 interest-free payments of $6.82 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Safety in these populations cannot be assumed based on the existing trial data
Low incidences of seizures have been reported with oral doses in individuals with or without pre-existing seizure disorders
It is shown that at the early phase of iPSC reprogramming, ROS levels increase, which activate NRF2, and it is important for navigating the transition [127]
While generally considered safe and effective, some individuals might experience adverse side effects
& Holtmann, G
US$ 25.70
US$ 26.30
US$ 29.30
US$ 23.03
US$ 25.10
US$ 25.51
US$ 26.36
